Skip to content

KetoAir PR

Qi Diagnostics is excited to announce our commercial launch of KetoAir Breathalyzer at the U.S. largest KetoCon AUSTIN 2023 conference!

(Hong Kong, 18 April 2023) We will be showcasing the KetoAir™ breathalyzer device and related accessories at the KetoCon Austin 2023 conference, booth #523, which is being held on April 21-23, 2023 in Austin, Texas.   KetoAir™ functions as a companion diagnostic and… Read More »Qi Diagnostics is excited to announce our commercial launch of KetoAir Breathalyzer at the U.S. largest KetoCon AUSTIN 2023 conference!

Qi Diagnostics and NasDaq-listed Avalon GloboCare Signed Agreement to Enter Diabetes Reversal and Weight Management Markets in The U.S. and European Regions

(Hong Kong, 14 April 2023) Qi Diagnostics Limited, a developer of innovative gas nanosensor technology and in vitro breath diagnostic devices, has announced that it has signed a memorandum of understanding (MOU) with Avalon GloboCare Corp. (NASDAQ: ALBT). Under the terms… Read More »Qi Diagnostics and NasDaq-listed Avalon GloboCare Signed Agreement to Enter Diabetes Reversal and Weight Management Markets in The U.S. and European Regions

en_US